ABOUT NORTH CAROLINA BIOTECHNOLOGY CENTER
The North Carolina Biotechnology Center leads life sciences economic development for North Carolina by supporting the progression of ideas from research lab to the marketplace. NCBiotech invests in technology development through grants, in company development through loans, and in economic development through partner development grants. NCBiotech is headquartered in the Research Triangle Park, with regional offices in Asheville, Charlotte, Greenville, Wilmington and Winston-Salem.
FEATURED ARTICLES
-
A vibrant community comes together to honor innovation, explore AI’s expanding role in healthcare, and highlight the collaborations, talent, and investment fueling rapid growth across the region.
-
A new workforce initiative combines training, data science, and immersive learning to prepare students for high-demand roles, offering a flexible pathway to strengthen talent pipelines.
-
A layoff became the spark for building a nimble analytical lab serving pharma and beyond. Discover how expertise, adaptability, and calculated risk-taking can unlock faster problem-solving.
-
Gain insight into a new collaboration that brings structure to rare disease trial referrals, improving how patients are matched, supported, and connected to study sites.
-
Take a look at how AI is transforming North Carolina’s life sciences sector, driving faster drug discovery, smarter manufacturing, and data-driven innovation, reshaping the future of therapeutics.
-
A former manufacturing site is reborn as a training hub that combines industry-shaped labs, employer-driven curriculum, and flexible programs to prepare a workforce ready for evolving demands.
-
Southeastern North Carolina is gaining momentum as a life sciences hub, fueled by new logistics infrastructure and workforce training, creating stronger connections across the region’s growing bioeconomy.
-
North Carolina is investing $230M+ in workforce training to support growth. Expanding facilities, modern curricula, and industry partnerships are building a pipeline equipped for production demands.
-
Charlotte’s health innovation community is gaining momentum through new networks, shared spaces, and startup support programs, turning collaboration into a catalyst for growth across the region.
-
Industry leaders in North Carolina discuss how automation, AI, workforce training, and collaboration are shaping the future of manufacturing, highlighting a shared focus on sustainable growth.
-
North Carolina’s life sciences success isn’t guaranteed. Industry leaders warn that global competition, infrastructure demands, and talent development will determine whether the state keeps its edge.
-
North Carolina’s life sciences sector saw nearly $3.8 billion in 2025 investments, expanded manufacturing capacity, and major workforce initiatives, reinforcing the state’s position as a national leader.
-
North Carolina’s expanding life sciences infrastructure is creating one of the world’s most integrated supply‑chain hubs and driving major investment across biopharma, agtech, and regulated research.
-
Charlotte’s life sciences ecosystem accelerated in 2025, anchored by expanding research capabilities. With deeper collaboration on the horizon, the region enters 2026 positioned for even greater momentum.
-
An expansion in Holly Springs highlights rising momentum, with increased investment, higher production capacity, and hundreds of new jobs. See how this project strengthens regional talent pipelines.
-
Eastern North Carolina is rapidly becoming a biomanufacturing powerhouse, capturing most of the state’s recent life sciences investment and job growth while expanding training programs.
-
A new federal initiative is advancing bioprinted kidney tissue engineered from a patient’s own cells, combining cutting‑edge bioprinting, bioinks, and bioreactors to address the growing donor shortage.
-
Learn more about a major life sciences investment that is bringing 500 new jobs to North Carolina, strengthening U.S. drug manufacturing, and advancing treatments for oncology and neurological diseases.
-
The first oral GLP-1 treatment for obesity is here, delivering significant weight loss and cardiovascular benefits.
-
Clinical trials are facing rising costs and complexity. Collaboration, data-driven strategies, and patient-centric models are reshaping research — uncover how leaders drive efficiency and innovation.
CONTACT INFORMATION
North Carolina Biotechnology Center
15 T.W. Alexander Drive
Durham, NC 27713
UNITED STATES
Phone: (919) 541-9366
NEWS
- JLL Names Research Triangle As Nation's Top Biomanufacturing Hub
- Astellas To Acquire Propella Therapeutics And Its Experimental Prostate Cancer Therapy
- Jaguar Gene Therapy Creates Spin-Off To Manage CMC Capabilities
- Conference Focuses On Need For Diversity In Clinical Research, Trials
- Biofidelity Introduces Novel Lung Cancer Assay For Precision Medicine
- NC Life Sciences Initiative And Building Support Future STEM Workforce
- CNBC Again Ranks North Carolina As 'Top State for Business In 2023'